Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Long Day's Journey Into Night for Lower-Risk Myelodysplastic Syndromes Jun 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Autoimmunity and Inflammation in Myelodysplastic Syndromes Jun 2016 Acta Haematol myelodysplastic syndromes (MDS)
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes Jun 2016 Leukemia myelodysplastic syndromes (MDS)
Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia Jun 2016 Cancer Res. myelodysplastic syndromes (MDS)
Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia Jun 2016 Int J Hematol aplastic anemia
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure Jun 2016 Blood myelodysplastic syndromes (MDS)
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ Jun 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes Jun 2016 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)
Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes Jun 2016 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)